114 related articles for article (PubMed ID: 23579462)
1. Histopathologic, immunohistochemical, and cytogenetic analysis of primary clear cell melanoma of the uvea.
Verdijk RM; Koopmans AE; Kilic E; Paridaens D; de Klein A
JAMA Ophthalmol; 2013 Jun; 131(6):814-6. PubMed ID: 23579462
[No Abstract] [Full Text] [Related]
2. Histopathologic, immunohistochemical, ultrastructural, and cytogenetic analysis of oncocytic uveal melanoma.
Verdijk RM; van den Bosch T; Naus NC; Paridaens D; Mooy CM; de Klein A
Arch Ophthalmol; 2011 Nov; 129(11):1501-2. PubMed ID: 22084225
[No Abstract] [Full Text] [Related]
3. A critical appraisal of the prognostic and predictive factors for uveal malignant melanoma.
Mudhar HS; Parsons MA; Sisley K; Rundle P; Singh A; Rennie IG
Histopathology; 2004 Jul; 45(1):1-12. PubMed ID: 15228438
[No Abstract] [Full Text] [Related]
4. Uveal melanoma: prognostication.
Turell ME; Tubbs RR; Biscotti CV; Singh AD
Monogr Clin Cytol; 2012; 21():55-60. PubMed ID: 22024584
[No Abstract] [Full Text] [Related]
5. Uveal melanoma: A pathologist's perspective and review of translational developments.
Schoenfield L
Adv Anat Pathol; 2014 Mar; 21(2):138-43. PubMed ID: 24508696
[TBL] [Abstract][Full Text] [Related]
6. Clinical, pathologic, and imaging features and biological markers of uveal melanoma.
Rashid AB; Grossniklaus HE
Methods Mol Biol; 2014; 1102():397-425. PubMed ID: 24258990
[TBL] [Abstract][Full Text] [Related]
7. Molecular karyotyping for detection of prognostic markers in fine needle aspiration biopsy samples of uveal melanoma.
Ganguly A; Richards-Yutz J; Ewens KG
Methods Mol Biol; 2014; 1102():441-58. PubMed ID: 24258992
[TBL] [Abstract][Full Text] [Related]
8. Cytogenetics of uveal melanoma: a 7-year clinical experience.
Damato B; Duke C; Coupland SE; Hiscott P; Smith PA; Campbell I; Douglas A; Howard P
Ophthalmology; 2007 Oct; 114(10):1925-31. PubMed ID: 17719643
[TBL] [Abstract][Full Text] [Related]
9. Pigmented spindle cell nevus: clues for differentiating it from spindle cell malignant melanoma. A comprehensive survey including clinicopathologic, immunohistochemical, and FISH studies.
Díaz A; Valera A; Carrera C; Hakim S; Aguilera P; García A; Palou J; Puig S; Malvehy J; Alos L
Am J Surg Pathol; 2011 Nov; 35(11):1733-42. PubMed ID: 21997694
[TBL] [Abstract][Full Text] [Related]
10. The future promise and the current reality of genetic prognostication in patients with uveal melanoma.
Tsai T; O'Brien JM
Arch Ophthalmol; 2008 Mar; 126(3):413-5. PubMed ID: 18332324
[No Abstract] [Full Text] [Related]
11. Cytogenetics in the management of uveal melanoma: are we there yet?
Robertson DM
Arch Ophthalmol; 2008 Mar; 126(3):409-10. PubMed ID: 18332323
[No Abstract] [Full Text] [Related]
12. Multiplex fluorescence in situ hybridization identifies novel rearrangements of chromosomes 6, 15, and 18 in primary uveal melanoma.
Sisley K; Tattersall N; Dyson M; Smith K; Mudhar HS; Rennie IG
Exp Eye Res; 2006 Sep; 83(3):554-9. PubMed ID: 16684523
[TBL] [Abstract][Full Text] [Related]
13. Elevated blood β-2 microglobulin is associated with tumor monosomy-3 in patients with primary uveal melanoma.
Triozzi PL; Elson P; Aldrich W; Achberger S; Tubbs R; Biscotti CV; Singh AD
Melanoma Res; 2013 Feb; 23(1):1-7. PubMed ID: 23196330
[TBL] [Abstract][Full Text] [Related]
14. Cytogenetics and prognosis for uveal melanoma in Korean patients.
Lee CS; Lee J; Choi JJ; Yang WI; Yoon JS; Lee SY; Lee SC
Acta Ophthalmol; 2011 Jun; 89(4):e310-4. PubMed ID: 21310015
[TBL] [Abstract][Full Text] [Related]
15. Molecular cytogenetic evaluation of 10 uveal melanoma cell lines.
White JS; Becker RL; McLean IW; Director-Myska AE; Nath J
Cancer Genet Cytogenet; 2006 Jul; 168(1):11-21. PubMed ID: 16772116
[TBL] [Abstract][Full Text] [Related]
16. Monosomy of chromosome 3 and an inflammatory phenotype occur together in uveal melanoma.
Maat W; Ly LV; Jordanova ES; de Wolff-Rouendaal D; Schalij-Delfos NE; Jager MJ
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):505-10. PubMed ID: 18234992
[TBL] [Abstract][Full Text] [Related]
17. Detection of genetic prognostic markers in uveal melanoma biopsies using fluorescence in situ hybridization.
Naus NC; Verhoeven AC; van Drunen E; Slater R; Mooy CM; Paridaens DA; Luyten GP; de Klein A
Clin Cancer Res; 2002 Feb; 8(2):534-9. PubMed ID: 11839674
[TBL] [Abstract][Full Text] [Related]
18. Clinical and cytogenetic analyses in uveal melanoma.
Kilic E; van Gils W; Lodder E; Beverloo HB; van Til ME; Mooy CM; Paridaens D; de Klein A; Luyten GP
Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3703-7. PubMed ID: 16936076
[TBL] [Abstract][Full Text] [Related]
19. [Genomic techniques used in uveal melanoma: a literature review].
Abi-Ayad N; Kodjikian L; Couturier J
J Fr Ophtalmol; 2011 Apr; 34(4):259-64. PubMed ID: 21439677
[TBL] [Abstract][Full Text] [Related]
20. Uveal melanoma: diagnostic features.
Biscotti CV; Singh AD
Monogr Clin Cytol; 2012; 21():44-54. PubMed ID: 22024583
[No Abstract] [Full Text] [Related]
[Next] [New Search]
